Page last updated: 2024-08-21

thiazoles and Epithelial Ovarian Cancer

thiazoles has been researched along with Epithelial Ovarian Cancer in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ledermann, JA1
Aghajanian, C; Barry, WT; Birrer, M; Buss, MK; Cadoo, KA; Cantley, LC; Coleman, RL; Curtis, J; D'Andrea, AD; Eismann, J; Farooq, S; Kaufmann, SH; Kirschmeier, P; Kochupurakkal, B; Konstantinopoulos, PA; Liu, J; Luo, W; Matulonis, UA; Mayer, EL; Mills, GB; O'Cearbhaill, RE; Palakurthi, S; Shapiro, GI; Swisher, EM; Westin, SN; Whalen, C; Winer, E; Wulf, GM1
Bocchicchio, S; Irusta, G; Tesone, M1
Chen, X; Dai, H; Qian, Z; Wang, Y; Xu, X; Zhao, Y1
Bae-Jump, VL; Chan, LL; Jones, HM; Ma, X; Song, F; Wang, J; Zhang, W; Zhou, C1
Cho, H; Chung, JY; Kang, ES; Kim, JH; Lee, EJ; Shin, HY; Yang, W1
Alpaugh, RK; Brady, WE; Fiorica, JV; Godwin, AK; Hu, W; Lankes, HA; Mannel, RS; Pathak, HB; Schilder, RJ; Shahin, MS; Sood, AK; Zhou, XC1

Trials

2 trial(s) available for thiazoles and Epithelial Ovarian Cancer

ArticleYear
Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial.
    The Lancet. Oncology, 2019, Volume: 20, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Genome, Human; Humans; Maximum Tolerated Dose; Middle Aged; Mutation; Ovarian Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Thiazoles; Treatment Outcome

2019
Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
    Gynecologic oncology, 2012, Volume: 127, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Ovarian Epithelial; Dasatinib; Disease-Free Survival; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Mas; Pyrimidines; Thiazoles

2012

Other Studies

5 other study(ies) available for thiazoles and Epithelial Ovarian Cancer

ArticleYear
Extending the scope of PARP inhibitors in ovarian cancer.
    The Lancet. Oncology, 2019, Volume: 20, Issue:4

    Topics: Carcinoma, Ovarian Epithelial; Female; Humans; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Thiazoles

2019
Convergence of Wnt and Notch signaling controls ovarian cancer cell survival.
    Journal of cellular physiology, 2019, Volume: 234, Issue:12

    Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Ovarian Epithelial; Cell Movement; Cell Proliferation; Cell Survival; Diamines; Female; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Pyrimidinones; Receptors, Notch; Signal Transduction; Thiazoles; Wnt Signaling Pathway; Xenograft Model Antitumor Assays

2019
In vitro chemosensitivity assay of ascites in epithelial ovarian cancer.
    European journal of gynaecological oncology, 2013, Volume: 34, Issue:6

    Topics: Antineoplastic Agents; Ascites; Carboplatin; Carcinoma, Ovarian Epithelial; Coloring Agents; Deoxycytidine; Disease Progression; Drug Screening Assays, Antitumor; Epirubicin; Etoposide; Female; Fluorouracil; Gemcitabine; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Survival Rate; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2013
Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells.
    Journal of translational medicine, 2014, Aug-21, Volume: 12

    Topics: Antineoplastic Agents; Apoptosis; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Carcinoma, Ovarian Epithelial; Cell Cycle Checkpoints; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Molecular Targeted Therapy; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Protein Multimerization; Proto-Oncogene Proteins c-myc; Thiazoles; Tumor Cells, Cultured; Tumor Stem Cell Assay

2014
Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer.
    Oncotarget, 2016, Aug-02, Volume: 7, Issue:31

    Topics: Animals; Apoptosis; Carcinoma, Ovarian Epithelial; CDC2 Protein Kinase; Cell Line, Tumor; Cisplatin; Cytoplasm; Female; Gene Expression Profiling; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phosphorylation; Prognosis; Proportional Hazards Models; Quinolines; ROC Curve; Survival Rate; Thiazoles; Time Factors; Tissue Array Analysis; Treatment Outcome

2016